References
- Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012;379(9835):2477–2488.
- Donnelly MC, Scobie L, Crossan CL, et al. Review article: hepatitis E – a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017;46(2):126–141.
- Okamoto H. Hepatitis E in patients with hematological disorders. Rinsho Ketsueki. 2018;59(10):1914–1923.
- Fraticelli P, Bagnarelli P, Tarantino G, et al. Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren’s syndrome. Rheumatology. 2016;55(12):2275–2277.
- Izopet J, Labrique AB, Basnyat B, et al. Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France. J Clin Virol. 2015;70:39–42.
- Meng XJ. Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis. 2013;33(1):41–49.
- Eyasu T, Dale H. Hepatitis E: epidemiology and prevention. World J Hepatol. 2011;3(12):285–291.
- Conway R, Doran MF, O’Shea FD, et al. The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis. Clin Rheumatol. 2014;33(12):1823–1827.
- Bauer H, Luxembourger C, Gottenberg J, et al. Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study. Medicine. 2015;94(14):e675.